Login
Super Investors Loomis Sayles Small Cap Growth Fund

Loomis Sayles Small Cap Growth Fund

Loomis Sayles Funds Ii · net assets $2.27B · 97 holdings as of June 30, 2026. Monthly N-PORT disclosure: the full book, not just equities.

Asset mix

EC: 97.4% · RA: 2.6%

Financial position

Total assets
$2.27B
Total liabilities
$1.98M
Net assets
$2.27B
Assets attributable to miscellaneous securities
$0
Assets invested in controlled foreign corporations
$0
Borrowings payable within one year
$0
Payable to controlled companies within one year
$0
Payable to other affiliates within one year
$0
Other liabilities payable within one year
$0
Borrowings payable after one year
$0
Payable to controlled companies after one year
$0
Payable to other affiliates after one year
$0
Other liabilities payable after one year
$0
Payables for delayed-delivery investments
$0
Payables for standby commitments
$0
Liquidation preference of outstanding preferred stock
$0
Cash not reported in Parts C or D
$0

Monthly flows and gains

Month 1 Month 2 Month 3
Sales $31.4M $15.5M $22.2M
Reinvestment $0 $0 $0
Redemptions $64.4M $52.3M $123M
Net realized gain (non-derivative) $14.8M $77.5M $33.9M
Net unrealized appreciation (non-derivative) $204M $-13.3M $202M

The three months of the reporting period, as filed; month 3 ends June 30, 2026.

Filing details

Registrant
Loomis Sayles Funds Ii
Registrant CIK
872649
Registrant LEI
5493007QOEDY6IHOTU14
Series
Loomis Sayles Small Cap Growth Fund
Series ID
S000006705
Series LEI
549300D7JABXY1Y68I26
SEC file number
811-06241
Address
888 BOYLSTON STREET, Suite 800, BOSTON, US-MA, 02199-8197, US
Phone
617-449-2139
Form
NPORT-P
Filed
August 28, 2026
Report period ends
September 30, 2026
Report month ends
June 30, 2026
Accession number
000141036826089897
Holding Value % of net assets
Fixed Income Clearing Corp. RA $58.1M 2.56%
Ligand Pharmaceuticals Inc EC $49.9M 2.20%
Esco Technologies Inc EC $48.6M 2.14%
Rbc Bearings Inc EC $46.4M 2.04%
Mercury Systems Inc EC $45.1M 1.99%
Extreme Networks Inc EC $44.4M 1.96%
Ati Inc EC $42.5M 1.87%
Macom Technology Solutions Holdings Inc EC $42.4M 1.87%
Advanced Energy Industries Inc EC $42.1M 1.85%
Establishment Labs Holdings Inc EC $39.6M 1.74%
Myr Group Inc EC $38.1M 1.68%
Aar Corp EC $38M 1.67%
Twist Bioscience Corp EC $37.1M 1.63%
Everus Construction Group Inc EC $36.1M 1.59%
Sterling Infrastructure Inc EC $36M 1.59%
Vita Coco Co Inc/the EC $35.8M 1.58%
Life Time Group Holdings Inc EC $34.3M 1.51%
Allegro Microsystems Inc EC $34.1M 1.50%
Construction Partners Inc EC $32.5M 1.43%
Axsome Therapeutics Inc EC $31.7M 1.40%
Marex Group PLC EC $31.7M 1.40%
Ducommun Inc EC $31M 1.37%
Alkermes PLC EC $31M 1.37%
Hexcel Corp EC $30.7M 1.35%
Arcosa Inc EC $30.6M 1.35%
Oceaneering International Inc EC $30M 1.32%
Silicon Motion Technology Corp EC $29.2M 1.29%
Vericel Corp EC $28.9M 1.27%
Mirum Pharmaceuticals Inc EC $28.1M 1.24%
Onespaworld Holdings Ltd EC $27.6M 1.22%
Pattern Group Inc EC $27M 1.19%
Onto Innovation Inc EC $26.9M 1.19%
Rhythm Pharmaceuticals Inc EC $26.1M 1.15%
Adeia Inc EC $25.1M 1.11%
Apogee Therapeutics Inc EC $24.3M 1.07%
Yeti Holdings Inc EC $24M 1.06%
Supernus Pharmaceuticals Inc EC $23.1M 1.02%
Fortrea Holdings Inc EC $23M 1.01%
Casella Waste Systems Inc EC $22.9M 1.01%
Pjt Partners Inc EC $22.5M 0.99%
Healthequity Inc EC $22.2M 0.98%
Glaukos Corp EC $22M 0.97%
Cactus Inc EC $21.8M 0.96%
Viavi Solutions Inc EC $21.6M 0.95%
Radnet Inc EC $21.4M 0.94%
Rambus Inc EC $20.9M 0.92%
Applied Industrial Technologies Inc EC $20.7M 0.91%
Patrick Industries Inc EC $20.4M 0.90%
Modine Manufacturing Co EC $20.3M 0.89%
Neogenomics Inc EC $20.1M 0.89%
Legence Corp EC $20.1M 0.89%
Wisdomtree Inc EC $20.1M 0.88%
Guardian Pharmacy Services Inc EC $19.7M 0.87%
Bbb Foods Inc EC $19.6M 0.87%
Piper Sandler Cos EC $19.6M 0.86%
Boot Barn Holdings Inc EC $19.1M 0.84%
Jfrog Ltd EC $19.1M 0.84%
Omada Health Inc EC $19M 0.84%
Alignment Healthcare Inc EC $18.9M 0.83%
Magnolia Oil & Gas Corp EC $18.4M 0.81%

Showing top 60 of 97 holdings.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support